Welcome to Kidney Cancer Care

Welcome to the McMaster University - St. Joseph’s Healthcare Kidney Cancer Centre of Excellence (KCCE) website. This is a patient-oriented portal providing information and links regarding the cutting edge management of kidney cancer. Here you will find up-to-date information about kidney cancer and its treatment, recent advances in management, current clinical research information, and links to our basic science research program. We hope you find this website informative and useful and we welcome your feedback.

Anil Kapoor, MD, FRCSC
Director
McMaster – SJH Kidney Cancer Centre of Excellence (KCCE)

Get the Flash Player to see this player.

 
What’s new in Kidney Cancer Care
October 13th, 2017
Cancer-specific mortality among patients who undergo surgery for non-metastatic renal cell carcinoma (RCC) vary according to histologic subtypes of the malignancy, new findings suggest.
September 10, 2017
MADRID, Sept 10 (Reuters) - A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients, data from a closely watched clinical trial showed on Sunday.
July 26th, 2017
Patients with metastatic renal cell carcinoma (RCC) had durable responses and manageable safety when treated with the combination of the immune checkpoint inhibitors nivolumab and ipilimumab, according to the results of the CheckMate 016 study published in the Journal of Clinical Oncology.